Dr Kirsty Hodgson Dr Ed Schwalbe Dr Jonathan Coxhead Naomi Sinclair Dr Simon Cockell et al. | Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome | 2019 |
|
Dr Marina Danilenko Elaine Stamp Dr Deborah Stocken Monique Zangarini Amy Cranston et al. | Targeting tropomyosin receptor kinase in cutaneous CYLD defective tumors (TRAC): A randomised placebo-controlled early phase trial with pegcantratinib | 2018 |
|
Professor Neil Rajan Naomi Sinclair Dr Sivakumar Natarajan
| A tale of two sisters: identical IL36RN mutations and discordant phenotypes | 2016 |
|
Professor Neil Rajan Naomi Sinclair Dr Kirsty Hodgson
| Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells | 2016 |
|
Professor Neil Rajan Naomi Sinclair Dr Kirsty Hodgson
| Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells | 2016 |
|
Professor Neil Rajan Naomi Sinclair Dr Sivakumar Natarajan
| Heterozygote IL36RN mutations in a European case of early-onset generalized pustular psoriasis challenge the concept of private mutation | 2014 |
|
Professor Neil Rajan Naomi Sinclair
| The Cylindromatosis gene product, CYLD, interacts with MIB2 to regulate Notch signalling | 2014 |
|
Professor Neil Rajan Naomi Sinclair
| The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate Notch signalling | 2014 |
|